Rascase 1.5mg (Rasburicase) 1.5mg

Rascase 1.5mg contains rasburicase, an enzyme used to manage uric acid levels in the blood. It helps prevent complications during cancer treatment by breaking down uric acid. This medication is typically administered as an injection under medical supervision. Short-term use focuses on rapid uric acid reduction.

Strength

1.5mg

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rascase 1.5mg is used to treat high uric acid levels caused by certain cancer treatments, such as chemotherapy. It works by converting uric acid into a substance that the body can easily eliminate. This helps prevent kidney damage and other complications. It may also be used for other conditions as determined by a healthcare provider.

Side Effects

After administration, Rascase 1.5mg begins breaking down uric acid in the bloodstream, which may lead to a gradual decrease in uric acid levels. Some patients may experience mild effects such as headache or nausea, though these are not guaranteed. The medication’s effects are monitored through blood tests to ensure proper uric acid management.

Precautions & Warnings

Rascase 1.5mg should only be handled and administered by healthcare professionals in a clinical setting. Patients with known allergies to rasburicase or any of its components should avoid this medication. Blood tests are typically required before and during treatment to monitor uric acid levels and overall response.

Avoid Interactions

Rascase 1.5mg has not been shown to interact significantly with common medications, but always inform your healthcare provider about all drugs you are taking. Certain conditions or medications may affect how rasburicase works, so a full medical history should be reviewed before starting treatment. No specific dietary restrictions are required, but hydration is encouraged.

References

Frequently Asked Questions

Rascase 1.5mg is used to lower high uric acid levels caused by cancer treatments like chemotherapy.

It is given as an injection by a healthcare professional, typically in a clinical or hospital setting.

No, Rascase 1.5mg should only be administered by a trained healthcare provider in a medical facility.

Some patients may experience headache or nausea, but these effects vary and are not experienced by everyone.

Yes, Rascase 1.5mg is a prescription medication and must be prescribed by a licensed healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.